Preliminary in vivo investigation of the mesenchymal stromal cell secretome as a novel treatment for methicillin-resistant Staphylococcus aureus in equine skin wounds.
Authors: Fahey Megan J, Harman Rebecca M, Thomas Matthew A, Pugliese Brenna R, Peters-Kennedy Jeanine, Delco Michelle L, Van de Walle Gerlinde R
Journal: Veterinary surgery : VS
Summary
# Editorial Summary Methicillin-resistant *Staphylococcus aureus* (MRSA) represents a significant clinical challenge in equine wound management, particularly where conventional antimicrobials have limited efficacy, prompting investigation into alternative therapeutic approaches. Researchers evaluated the antimicrobial and healing properties of mesenchymal stromal cell-conditioned media (MSC-CM)—the secreted products of cultured equine mesenchymal stromal cells—using an in vivo model where MRSA was deliberately inoculated into thoracic wounds in horses. The secretome approach capitalises on the known immunomodulatory and antimicrobial properties of MSC-derived substances without requiring cell implantation itself, potentially offering a more practical application pathway. Key findings demonstrated that MSC-CM treatment reduced bacterial burden and promoted tissue healing responses in MRSA-infected wounds, suggesting that paracrine factors produced by mesenchymal stromal cells possess genuine therapeutic potential against this problematic pathogen. For practitioners managing equine wounds complicated by MRSA or other antibiotic-resistant infections, these preliminary results indicate that cell-derived secretome products warrant further development as an adjunctive or alternative treatment strategy, though additional clinical validation will be necessary before translating this approach into routine practice.
Read the full abstract on PubMed
Practical Takeaways
- •Cell-free secretome products may offer a non-invasive alternative to conventional antibiotics for treating resistant bacterial wound infections in horses
- •This emerging regenerative medicine approach could complement standard wound management protocols, particularly for MRSA-contaminated cases
- •Further clinical trials are needed before secretome-based therapies can be integrated into routine equine wound care
Key Findings
- •Mesenchymal stromal cell-conditioned media (MSC-CM) was investigated as a novel antimicrobial treatment for MRSA-contaminated equine skin wounds
- •Study represents preliminary in vivo investigation of secretome-based therapy for wound healing and infection control in equine dermatology
- •MSC-CM demonstrated potential as a pro-healing agent with antimicrobial properties in the experimental model